Iron is an essential nutrient. Its deficiency hinders the synthesis of ATP and DNA. We report that galactose metabolism is defective when iron availability is restricted. Our data support this connection because: (1) galactose mediated induction of GAL promoter dependent gene expression was diminished by iron limitation, and (2) iron-deficient mutants grew slowly on galactose containing medium. These two defects were immediately corrected by iron replacement. Inherited defects in human galactose metabolism are characteristic of the disease called galactosemia. Our findings suggest that iron deficient galactosemic individuals might be more severely compromised than iron replete individuals. This work shows that iron homeostasis and galactose metabolism are linked with one another.
Introduction
Iron acts as an enzyme cofactor and protein structural component in living organisms. It is indispensable for an array of metabolic functions including cellular energy production and DNA synthesis (1, 2) . Iron-deficient anemia is known to impair immune function and cognitive development (3) (4) (5) (6) . Iron can also be toxic when present in excess. Iron toxicity has been partly implicated in neurodegenerative diseases, aging, microbial infection and cancer (7) (8) (9) (10) (11) (12) . Since iron is essential and toxic, its intracellular content must be tightly controlled.
Normal iron homeostasis requires the presence of copper, which is also an essential nutrient. High-affinity iron uptake in the yeast Saccharomyces cerevisiae is Cu 2+ -dependent because Fet3p, a component of the high-affinity iron transporter complex, is a Cu 2+ -dependent ferrous oxidase (13) (14) (15) (16) (17) (18) (19) . This interaction was demonstrated when a yeast deletion mutant of the high-affinity copper transporter CTR1 was unable to take up iron until supplemented with copper (20) . Copper deficiency is known to lead to iron-deficient anemia in mammals as a result of the inactivity of ceruloplasmin, a Fet3 homologue (8, 21, 22) .
Since copper influences iron homeostasis, we hypothesized that iron might in turn affect copper homeostasis. To find if iron influences copper uptake, we compared the level of Ctr1p under iron deficiency and iron excess. Since CTR1 transcription was unaffected by changes in iron conditions (23), we placed the control of CTR1 expression under a galactose-inducible GAL1 promoter to see if iron status influences CTR1 expression post-translationally (24, 25) . Our investigation serendipitously led us to discover that GAL gene expression is inhibited when iron is limited, and that galactose is not metabolized in naturally iron-deficient cells. This defect is reminiscent of the inability of a galactosemic to metabolize galactose (26, 27) .
by guest on http://www.jbc.org/ Downloaded from 4
Materials and Methods

Yeast strains
The yeast strains used in this study were ZY60 
Effects of iron deficiency on galactose metabolism
Iron chelation and galactose induction of GAL1 promoter
Cells bearing the plasmid p414GAL-CTR1myc were grown over night in synthetic complete medium lacking tryptophan (SC-TRP) with raffinose (2%) in the place of glucose. Cells were re-inoculated into medium of the same composition with or without bathphenathroline disulfonate (BPS) (28) , at a starting OD 600 of 0.4. Galactose (0.5%) was added and cells were grown until an OD 600 of 0.8-1.0 was attained. Yeast whole cell extracts were prepared, and Ctr1-Myc was detected by western blotting using antiMyc antibodies (24) .
AFT1/FET3-deletion and galactose induction of GAL1 activity
The plasmid p414GAL-CTR1myc was transformed into the strains ZY60 (WT), ZY89 (aft1 ), and ZY90 (fet3 ). Cells were grown in SC-TRP containing raffinose (2%), 
Growth analysis of iron deficient cells on galactose medium
Strains BY4741, BY4741aft1 , BY4741fet3 , and BY4741gal7 were streaked onto SC medium containing glucose or galactose. The plates were produced with or without (NH 4 )Fe(SO 4 ) 2 . Cells were incubated at 30°C for four days and photographed.
Results
Galactose induction of GAL gene expression is inhibited under iron deficient conditions
We initially sought to find if changes in iron conditions affect copper uptake.
Since Ctr1p undergoes Mac1p-dependent turnover in response to increasing copper concentrations (24, 25), we used yeast strain ZY60, which does not express Mac1p.
This strain allowed us to eliminate copper-triggered Ctr1p degradation. ZY60 strain with the p414GAL-CTR1myc tag was grown in standard laboratory medium (an iron-normal condition) and in medium containing the iron chelator bathophenanthroline disulfonate (BPS) to cause iron deficiency (28) . GAL1-driven Ctr1-Myc expression was induced by growth on galactose and analyzed by western blotting using anti-Myc antibody (9E10).
As shown in Figure 1A , left panel, the Ctr1-Myc level was much lower in the BPStreated samples than in the controls. Under the same conditions, no changes in phosphoglycerokinase (PGK) level were detected, indicating that the BPS effect was specific to CTR1 expression. Therefore, GAL1-driven CTR1 expression appears to be inhibited when iron is limited.
We were concerned that the observed effect of BPS might be caused by changes other than iron limitation. We reasoned that iron addition should ameliorate the change in CTR1 expression. To find if we were correct, we first treated cells with BPS and then with Fe 3+ salt. The data in Figure 1A , right panel, show that the addition of exogenous Fe 3+ ions to the BPS-treated cells raised the Ctr1-Myc level in a dosedependent fashion. We also compared GAL promoter driven CTR1 expression (from p414GAL-CTR1myc) in the wild type (WT) and fet3 or aft1 mutants (28, 29) . AFT1
encodes an iron-sensing transcription factor that activates the transcription of FET3 and other genes in iron-transporting pathways (28) . Thus, these mutants would be expected to be relatively iron starved compared with the wild type. The data in Figure 1B show that the Ctr1-Myc levels were much lower in the two mutants than in the wild type.
When the mutants were grown in Fe 3+ -supplemented medium the Ctr1-Myc levels increased significantly. In contrast, the PGK level remained constant under the same conditions. These results show that GAL1-driven CTR1 expression is indeed repressed under iron deficient conditions.
To address a concern that GAL1 promoter activity might be inhibited by iron limitation, we repeated the above experiment using a single copy plasmid pCTR1-myc (provided by Andy Dancis) in which CTR1-myc expression is under the control of the wild type CTR1 promoter (24) . We initially detected a modest reduction in Ctr1-Myc level in BPS-treated cells with respect to control cells (data not shown). However, this result was not reproducible. These results led us to suspect that iron deficiency might instead inhibit galactose-induction of the GAL1 promoter. To explore this possibility we used strain SH26, which has SWE1 under the control of GAL promoter, and GAL-SWE1
is integrated into the genome. SWE1 encodes a protein kinase that is involved in the cell cycle (30) and there is currently no indication that SWE1 function is affected by iron.
The cells were grown in galactose medium either in the absence or presence of BPS and Swe1p was detected by western blotting with anti-Swe1 antibody. As presented in Figure 1C Based on these results we concluded that the galactose-induction of the GAL1 promoter is defective when iron is deficient.
Iron-deficient mutants show defective utilization of galactose for growth
The data in Figure 1 indicate that the expression of galactose-metabolizing genes is likely reduced under iron deficient conditions, so one could infer that the ability of iron-deficient cells to metabolize galactose would be reduced accordingly. We compared the growth of wild type (WT) and aft1 and fet3 cells on medium containing either glucose or galactose with or without Fe 3+ salt. For controls we used an isogenic gal7 mutant. GAL7 encodes an uridyltransferase for metabolizing galactose (31) .
Deficiencies in human uridyltransferase activity cause the disease galactosemia (26, 27) . As shown in Figure 2 , left panel, the wild type, aft1 , fet3 and gal7 strains grew equally well on glucose medium. On galactose medium, the aft1 and fet3 cells exhibited an obvious slow growth, the gal7 mutant did not grow at all, and the wild type grew normally (middle panel), indicating that the naturally iron-deficient aft1 and fet3 mutants are indeed defective in their ability to metabolize galactose. When high levels of exogenous Fe 3+ ions were present, both the aft1 and fet3 mutants, but not the gal7 , were able to grow on galactose medium (right panel), suggesting that the defect of aft1 and fet3 cells to metabolize galactose is probably due to a lack of iron
Discussion
We have shown that galactose metabolism was altered by iron deficiency. We found that galactose dependent induction of GAL promoter driven gene expression was inhibited when iron was lacking, and that iron-deficient cells had a diminished ability to grow on galactose medium. These two defects were corrected by iron replacement, demonstrating a requirement of iron for normal galactose metabolism. Therefore, iron homeostasis and galactose metabolism are connected with one other. conditions. This possibility is consistent with our observation that iron application rescued the growth of naturally iron-deficient cells on galactose medium (Figure 2 ).
However, if this were true, how could reduction in Gal7p activity inhibit GAL gene induction by galactose? One has to assume that galactose induction of the GAL gene is dependent on galactose metabolism itself as previously hypothesized (34) , and that Gal7p might be involved in the production of an inducer molecule, perhaps UDP-Gal.
We made this assumption since Gal7p catalyzes the production of UDP-Gal in the galactose metabolism pathway (33) . To examine this assumption, we induced GAL driven CTR1-MYC expression with galactose in the wild type and gal7 strain and treated cells with BPS. We found that CTR1-MYC expression was drastically reduced in the gal7 strain in comparison to the wild type ( Figure 3 ). This result offers further evidence that galactose induction of GAL gene expression is dependent on galactose by guest on http://www.jbc.org/ Downloaded from metabolism. Furthermore, in the gal7 strain the CTR1-MYC expression was still repressed by BPS treatment as in the wild type, suggesting that a lack of iron might affect factor(s) other than Gal7p in terms of GAL gene expression. We also tested whether UDP-Gal is able to induce the GAL expression in the absence of galactose in intact cells and spheroplasts, and found that GAL driven CTR1-MYC expression was not induced (data not shown).
Additionally, an earlier study showed that galactose induction of GAL gene expression was affected by mitochondria function with respect to the IMP1 gene, which encodes an inner membrane peptidase (36, 37) . The wild type IMP1 strain could grow on and ferment galactose only in respiratory-deficient conditions, and the strains carrying recessive allele imp1 of the IMP1 could also grow on and ferment galactose, but only under respiratory-sufficient conditions (36) . Since a lack of iron leads to respiratory deficiency (1), the iron deficiency-related inhibition of GAL gene induction could be due to defective mitochondria function. However, the strains used in this study all carry IMP1. When iron is lacking one would expect the GAL gene to be induced by galactose and the naturally iron deficient cells to be able to grow on galactose medium,
which is not what we observed. Therefore, the effect of iron deficiency on GAL gene induction might not be wholly linked to mitochondria dysfunction. A recent genomewide microarray that compared glucose and galactose-grown wild type and GAL gene deletion mutants found that expression of iron and copper transporter genes was altered (38) . This profile suggests that there might be coordination between sugar metabolism and metal ion homeostasis, at least with respect to iron and copper. Also, iron might influence galactose metabolism through a mechanism that has yet to be discovered.
The discovery that iron deficiency impairs a cell's ability to metabolize galactose Isogenic strains BY4741 (WT), BY4741aft1 , BY4741fet3 and BY4741gal7 were streaked onto agar containing synthetic complete medium with glucose (GLUCOSE), or galactose (GALACTOSE), or galactose and exogenous iron salt at 10 µM concentration (GALACTOSE+Fe). Cells were incubated and 30°C for four days and then photographed.
